naltrexone has been researched along with Heroin Abuse in 299 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 91 (30.43) | 18.7374 |
| 1990's | 48 (16.05) | 18.2507 |
| 2000's | 123 (41.14) | 29.6817 |
| 2010's | 36 (12.04) | 24.3611 |
| 2020's | 1 (0.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, LM; Lee, JD; Nelson, LS; Smith, SW; Wightman, RS | 1 |
| Bisaga, A; Levin, FR; Mariani, JJ; Mishlen, K; Nunes, EV; Sibai, M | 1 |
| Carton, L; Gaboriau, L; Lescut, C; Rolland, B | 1 |
| Bal, C; Posch, C; Rappersberger, K | 1 |
| Cotton, A; Elton, P; Irving, P; Jones, S; McNeill, J; Mohammed, F; Monk, R; Murphy, PN; Sharples, L; Wareing, M | 1 |
| Hulse, GK; Reece, AS | 1 |
| Brewer, C; de Jong, C; Williams, J | 1 |
| Crawford, EF; George, O; Koob, GF; Park, PE; Schlosburg, JE; Vendruscolo, LF; Whitfield, TW | 1 |
| Matthew-Simmons, F; Ritter, A | 1 |
| Fürst, Z; Hosztafi, S | 1 |
| Meyer, AC; Miller, ME; Sigmon, SC | 1 |
| Booij, J; de Bruin, K; Goudriaan, AE; Koeter, MW; Lammers, LA; van den Brink, W; van Dijk, L; Zaaijer, ER | 1 |
| Blady, SJ; Elman, I; Hyatt, JM; Langleben, DD; Lowen, SB; Lynch, KG; O'Brien, CP; Wang, AL | 1 |
| Bisaga, A; Drill, ES; Khan, NA; Mogali, S; Nunes, E; Pavlicova, M; Sullivan, MA | 1 |
| Ang, A; Cousins, SJ; Crèvecoeur-MacPhail, D; Darfler, K; Radfar, SR; Rawson, RA | 1 |
| Ayranci, G; Befort, K; Filliol, D; Gavériaux-Ruff, C; Kieffer, BL; Lalanne, L; Lutz, PE | 1 |
| Booij, J; Goudriaan, AE; Koeter, MW; van den Brink, W; Zaaijer, ER | 1 |
| Bigelow, GE; DeFulio, A; Dunn, KE; Everly, JJ; Fingerhood, M; Holtyn, AF; Jarvis, BP; Leoutsakos, JS; Silverman, K; Umbricht, A | 1 |
| Chawarski, MC; Mazlan, M; Schottenfeld, RS | 2 |
| O'Brien, CP | 2 |
| Fishman, M | 1 |
| Lee, SS; Merican, MI; Noordin, NM; Rahman, HA; Ramly, R | 1 |
| Lloyd-Jones, DM | 1 |
| Meyer, F | 1 |
| Little, M; Murray, LM | 1 |
| Brewer, CL | 1 |
| Kozminsky, MP | 1 |
| Kalivas, PW; Lai, M; Liu, H; Tang, S; Zhang, F; Zhou, W; Zhu, H | 1 |
| Newman, RG | 1 |
| Dolan, K; Larney, S | 1 |
| Bisaga, A; Brooks, AC; Carpenter, KM; Comer, SD; Jiang, H; Nunes, EV; Raby, WN; Sullivan, MA | 1 |
| Gossop, M; Hegstad, S; Hjerkinn, B; Kristensen, Ø; Kunøe, N; Lobmaier, P; Vederhus, JK; Waal, H | 1 |
| Andrian, V; Georgiou, V; Katsakiori, P; Lyros, E; Messinis, L; Panagis, G; Papathanasopoulos, P | 1 |
| Arnold-Reed, D; Hulse, GK; Morris, N; Tait, RJ | 1 |
| Kelly, KI; McBride, A | 1 |
| Ladanyi, A; Moss, J; Temkin, SM | 1 |
| Blokhina, EA; Krupitsky, EM | 1 |
| Hulse, GK; Ngo, HT; Tait, RJ | 4 |
| Amato, L; Bargagli, AM; Davoli, M; Diecidue, R; Faggiano, F; Jarre, P; Perucci, CA; Salamina, G; Schifano, P; Vigna-Taglianti, F | 1 |
| Bisaga, A; Brooks, AC; Carpenter, KM; Comer, SD; Nunes, EV; O'Brien, CP; Raby, WM; Sullivan, MA; Yu, E | 1 |
| Amar, R; Casarella, J; Drexler, K; Fareed, A; Vayalapalli, S | 1 |
| Bespalov, AIu; Burakov, AM; Didenko, TIu; Egorova, VIu; Grineneko, AIa; Ivanova, EB; Krupitskiĭ, EM; Masalov, DV; Neznanov, NG; O'Brien, C; Romanova, TN; Tsoĭ-Podosenin, MV; Verbitskaia, EV; Woody, D; Zvartau, EE | 1 |
| Law, F; Melichar, J; O'Shea, J | 1 |
| Chawarski, M; Luekens, C; Mazlan, M; Ng, N; Ruger, JP; Schottenfeld, R | 1 |
| Busch, EL; Childress, AR; Cornish, J; Elman, I; Langleben, DD; Loughead, JW; Lynch, KG; Nuwayser, ES; O'Brien, CP; Ruparel, K | 1 |
| Blokhina, E; Föhr, J; Kiviniemi, V; Krupitsky, E; Kuoppasalmi, K; Mamontova, O; Tiihonen, J; Tuomola, P; Verbitskaya, E; Zwartau, E | 1 |
| Blokhina, E; Burakov, A; Bushara, N; Krupitsky, E; Masalov, D; Palatkin, V; Pecoraro, A; Romanova, T; Slavina, T; Tsoy-Podosenin, M; Tyurina, A; Verbitskaya, E; Wahlgren, V; Woody, GE; Zvartau, E | 1 |
| Aklin, WM; Bigelow, GE; Fingerhood, M; Lejuez, CW; Severtson, SG; Silverman, K; Umbricht, A | 1 |
| Hulse, G; Kunøe, N; Lobmaier, P; Ngo, H | 1 |
| Chawarski, M; Mazlan, M; Ng, N; Ruger, JP; Schottenfeld, R | 1 |
| Hulse, G; Kelty, E; Ngo, H | 1 |
| Waal, H | 1 |
| Chisolm, MS; Jansson, LM; Jones, HE; Terplan, M | 1 |
| Brewer, C | 2 |
| Ali, R; Gowing, L; McGregor, C; Thomas, P; White, JM | 1 |
| Amato, L; Davoli, M; Ferri, A; Kirchmayer, U; Perucci, CA; Verster, AD | 1 |
| Hulse, G; O'Neil, G | 1 |
| Bertschy, G; Besson, J; Bochud Tornay, C; Daeppen, JB; Favrat, B; Monnat, M; Schnyder, C | 1 |
| Kerkhof, AJ; Roozen, HG; van den Brink, W | 1 |
| Aamodt, Ø; Olsen, H; Waal, H | 1 |
| Armstrong, PA; Boyce, SH; Stevenson, J | 1 |
| Brewer, C; Foster, J; Steele, T | 1 |
| Kleber, HD | 1 |
| Bussandri, M; Ceresini, S; Esposito, A; Gerra, G; Moi, G; Molina, E; Raggi, MA; Zaimovic, A | 1 |
| Hulse, GK; Tait, RJ | 1 |
| Arnold-Reed, DE; Basso, MR; Hansson, RC; Holman, CD; Hulse, GK; Murray, SD; O'Neil, G | 1 |
| Grinenko, AIa; Krupitskiĭ, EM; Zvartau, EE | 1 |
| Izenwasser, S; Platt, DM; Rowlett, JK; Spealman, RD | 1 |
| Ali, R; Athanasos, P; Danz, C; Gowing, L; McGregor, C; Stegink, A; Thomas, P; White, J | 1 |
| Aksel'rod, BA; Chichenkov, TO; Kubarev, DA; Savchenkov, VA; Sivolap, I | 1 |
| Alvarez, CE; Bascarán, MT; Bobes, J; Carreño, JE; Díaz, M; Narciso, GI | 1 |
| Arnold-Reed, DE; Hansson, RC; Hulse, GK; O'Neil, G | 1 |
| Castellano, M; Cervera, G; Martínez-Raga, J; Perez-Galvez, B; Sabater, A | 1 |
| Arnold-Reed, DE; Hulse, GK; O'Neil, G | 1 |
| Freye, E; Levy, JV; Partecke, L | 1 |
| Bespalov, AY; Burakov, AM; Didenko, TY; Egorova, VY; Grinenko, AY; Ivanova, EB; Krupitsky, EM; Masalov, DV; Neznanov, NG; O'Brien, CP; Romanova, TN; Tsoi, MV; Verbitskaya, EV; Woody, GE; Zvartau, EE | 1 |
| Arnold-Reed, DE; Chan, CT; Hansson, RC; Hulse, GK; O'Neil, G | 1 |
| Arnold-Reed, DE; Chan, CT; Hansson, R; Hulse, GK; O'Neil, G; O'Neil, P | 1 |
| Brewer, C; Wong, VS | 1 |
| Bell, JR; Mattick, RP; Rea, F; Young, MR | 1 |
| Beaini, AY; Carr, MP; Firth, AY; Pulling, S | 1 |
| Jackson, H; Maher, C; Ritter, A; Tucker, T | 2 |
| Ali, R; Bell, J; Breen, C; Digiusto, E; Kimber, J; Lintzeris, N; Mattick, RP; Saunders, JB | 1 |
| Arnold-Reed, D; Comer, SD; Hulse, GK; Jacobs, IG; Sullivan, MA; Tait, RJ | 1 |
| Kunøe, N; Lobmaier, P | 1 |
| Ali, R; Bell, J; Digiusto, E; Doran, CM; Gilmour, S; Lintzeris, N; Mattick, RP; Saunders, JB; Shanahan, MD; White, J | 1 |
| Antonilli, L; Badiani, A; Caprioli, D; Nencini, P; Petecchia, E | 1 |
| Besson, J; Broers, B; Dorogy, F; Favrat, B; Krenz, S; Muller, J; Zimmermann, G; Zullino, D; Zwahlen, A | 1 |
| Gölz, J; Grüsser, SM; Partecke, G; Platz, W; Thalemann, CN | 1 |
| Collins, ED; Heitler, NE; Kleber, HD; Whittington, RA | 1 |
| O'Connor, PG | 1 |
| Hulse, GK; McCallum, D; Morris, N; O'neil, G; Smit, W; Stalenberg, V; Tait, RJ | 1 |
| Byrne, A; Graham, G; Hallinan, R; Murnion, B | 1 |
| Graham, R; Wodak, A | 1 |
| Evans, B; Graham, JM | 1 |
| Fantoma, A; Gerra, G; Zaimovic, A | 1 |
| Comer, SD; Dackis, C; Kampman, K; Kleber, HD; O'Brien, CP; Rothenberg, JL; Sullivan, MA; Yu, E | 1 |
| Miller, MM | 1 |
| Besson, J; Favrat, B | 1 |
| Connor, JP; Dean, AJ; Jones, RT; Lawford, BR; Saunders, JB; Young, RM | 1 |
| Cornish, JW; O'Brien, C | 1 |
| Nordstrom, BR; Patapis, NS | 1 |
| Bonnie, RJ | 1 |
| Presenza, LJ | 1 |
| Marlowe, DB | 1 |
| Comer, SD; Sullivan, MA; Vosburg, SK | 1 |
| Bespalov, AY; Burakov, AM; Didenko, TY; Egorova, VY; Grinenko, AY; Ivanova, EB; Krupitsky, EM; Masalov, DV; Neznanov, NG; O'Brien, CP; Romanova, TN; Tsoy, MV; Verbitskaya, EV; Woody, GE; Zvartau, EE | 1 |
| Carpenter, KM; Kleber, HD; Nunes, EV; Rothenberg, JL; Sullivan, MA | 1 |
| Besson, J; Camarasa, X; Khazaal, Y; Zullino, DF | 1 |
| Arnold-Reed, DE; Hulse, GK; Ngo, HT; Tait, RJ | 1 |
| Stancliff, S | 1 |
| Bridden, C; Cheng, DM; Edwards, EM; Egorova, VY; Krupitsky, EM; Raj, A; Samet, JH; Walley, AY; Woody, GE; Zvartau, EE | 1 |
| Burakov, AM; Egorova, VY; Grinenko, AY; Kruptisky, EM; Slavina, TY; Tsoy, MV; Woody, GE; Zvartau, EE | 1 |
| Bluschke, SM; De Jong, CA; Dijkstra, BA; Krabbe, PF; van der Staak, CP | 1 |
| Rastegar, DA | 1 |
| Arnold-Reed, DE; Hansson, RC; Hulse, GK; Ngo, HT; Tait, RJ | 1 |
| Akerele, E; Anen, SJ; Bisaga, A; Brooks, AC; Carpenter, K; Comer, SD; Garawi, F; Jiang, H; Nunes, EV; Raby, WN; Sullivan, MA | 1 |
| Barr, CS; Heilig, M; Kakko, J; Lidström, J; Svanborg, KD; von Wachenfeldt, J | 1 |
| Gardner, TJ; Kosten, TR | 1 |
| Arnold-Reed, DE; Bulsara, MK; Gawthorne, G; Holman, CD; Hulse, GK; O'Neil, P; Rodiguez, C; Tait, RJ | 1 |
| Bigelow, GE; Chausmer, AE; Strain, EC; Walsh, SL | 1 |
| Reece, AS | 1 |
| Bozinovska, C; Dejanova, B; Pereska, Z; Petkovska, L | 1 |
| Arout, CA; Inturrisi, CE; Juni, A; Kest, B; Klein, G; Waxman, AR | 1 |
| Haber, PS; Lee, S; Lintzeris, N; Mabbutt, J; Scopelliti, L | 1 |
| Goldstein, A; Inturrisi, CE; Judson, BA | 1 |
| Childress, AR; Ehrman, RN; McLellan, AT; O'Brien, CP; Ternes, J | 1 |
| Rawson, RA; Tennant, FS | 1 |
| Arndt, IC; Evans, B; Greenstein, RA; McLellan, AT; O'Brien, CP | 1 |
| Cohen, AJ; Mann, A; Rawson, RA; Tennant, FS | 1 |
| Goldstein, A; Judson, BA | 1 |
| Greenstein, RA; Resnick, E; Resnick, RB | 1 |
| Kuehnle, JC; Mello, NK; Mendelson, JH; Sellers, ML | 1 |
| Ellingboe, J; Mendelson, JH; Meyer, RE; Mirin, SM | 1 |
| Renault, PF | 3 |
| Archer, S | 1 |
| Resnick, RB; Stone-Washton, N; Washton, AM | 1 |
| Carney, TM; Goldstein, A; Judson, BA | 1 |
| Resnick, RB; Washton, AM | 2 |
| Ellingboe, J; Kuehnle, JC; Mendelson, JH | 1 |
| Ellingboe, J; Kuehnle, JC; Mello, NK; Mendelson, JH | 1 |
| Kuehnle, JC; Mello, NK; Mendelson, JH; Sellers, MS | 1 |
| Arias, R; Callahan, EJ; Glazer, M; Liberman, RP; McCleave, B; Rawson, RA | 1 |
| Miguel, N; Patricio, LD | 1 |
| Azatian, A; Joseph, H; Papiasvilli, A | 1 |
| Jamaludin, A; Mansor, SM; Mohamed, M; Navaratnam, V; Raman, N | 1 |
| Gossop, M; Legarda, JJ | 1 |
| Baldelli, C; Benincasa, E; De Luca, A; Domenici, B; Galante, A; Pietroiusti, A; Tiratterra, F; Valenzi, C | 1 |
| Bar-Hamburger, R; Gandacu, D; Ginath, Y; Porat, S; Shufman, EN; Witztum, E | 1 |
| Cavigliano, P; Fossati, G; Frigo, G; Lecchini, S; Mazzone, A; Mazzucchelli, I; Notario, A; Pasotti, D; Ricevuti, G | 1 |
| Porat, S; Shufman, EN; Witztum, E | 1 |
| KOSTEN, TR | 1 |
| Galloway, G | 1 |
| Chaudhry, H; Hofmann, P; Loimer, N | 1 |
| Fritzinger, BK; Heller, J; Nakayama, GR; Roskos, KV; Tefft, JA | 1 |
| Dworkin, SI; Martin, TJ; Sizemore, GM; Smith, JE; Walker, LE | 1 |
| Avanzini, P; Caccavari, R; Delsignore, R; Fertonani, G; Gerra, G; Lucchini, A; Rota-Graziosi, I; Zaimovic, A | 1 |
| Bartter, T; Gooberman, LL | 1 |
| Ehrenreich, H; Poser, W | 1 |
| Compton, P; Pasero, CL | 1 |
| Yeo, BK | 1 |
| Carroll, KM; Kosten, TR; O'Connor, PG; Rounsaville, BJ; Schottenfeld, RS; Shi, JM | 1 |
| Alvarez, M; Cabré, L; Carrasco, G; Costa, J; Hernández, E; Molina, R; Puiggrós, A; Seoane, A; Sobrepere, G | 1 |
| Caplehorn, JR | 1 |
| Hall, W; Mattick, RP | 1 |
| Dyer, C | 1 |
| Araluce, K; Calle, R; Fernádez de Corres, B; Gutiérrez-Fraile, M; Iraurgi, I; Jiménez-Lerma, JM; Landabaso, MA; Sanz, J | 1 |
| DeMontis, MG; Dworkin, SI; Kim, SA; Martin, TJ; Sizemore, GM; Smith, JE | 1 |
| Bargagli, AM; D'Ippoliti, D; Davoli, M; Pasqualini, F; Perucci, CA | 1 |
| Avico, U; Bertolotti, M; Dell'Utri, A; Ferrari, A; Sternieri, E | 1 |
| Bertschy, G; Cucchia, AT; Ferrero, F; Monnat, M; Spagnoli, J | 1 |
| Hirtl, C; Pfab, R; Zilker, T | 1 |
| Heller, J; Roskos, KV; Tefft, JA | 1 |
| DeJesus, A; Montoya, ID; Preston, KL; Schuster, CR; Silverman, K; Umbricht, A | 1 |
| Caldiroli, E; Cattaneo, S; Fietta, AM; Frigo, GM; Lecchini, S; Leoni, O; Marino, V; Mazzone, A; Rasini, E; Tosetto, C | 1 |
| Gerada, C; Kemp, K; Smith, P | 1 |
| Hall, WD; Wodak, A | 1 |
| Bammer, G; Bell, JR; Masterman, SC; Mattick, RP; Morris, A; Young, MR | 1 |
| Chiang, CT; Demuth, KL; Hoover, DR; Montoya, ID; Preston, KL; Umbricht, A | 1 |
| De Giacomo, M; De Risio, S; Janiri, L; Mannelli, P; Pozzi, G | 1 |
| Taylor, LK; Thackway, SV; Ward, PL | 1 |
| Adams, M; Curry, KH; Zador, DA | 1 |
| Spanagel, R | 1 |
| de Jong, CA; Krabbe, PF; Laheij, RJ | 1 |
| Hensel, M; Kox, WJ | 1 |
| Bocchi, C; Delsignore, R; Fontanesi, B; Gerra, G; Rustichelli, P; Timpano, M; Zaimovic, A; Zambelli, U | 1 |
| Arrazola, X; Gutiérrez-Fraile, M; Iraurgi, I; Jiménez-Lerma, JM; Landabaso, MA | 1 |
| Chanmugam, AS; Ezenkwele, U; Hengeller, M | 1 |
| Eichmiller, PR; Gorelick, DA; Heishman, SJ; Hill, BH; Liberto, JG; Norbeck, J; Rothman, RB | 1 |
| Kishioka, S; Paronis, CA; Woods, JH | 1 |
| Fiellin, DA; O'Connor, PG | 1 |
| Bearn, J; Buntwal, N; Gossop, M; Strang, J | 1 |
| Gibbons, N; Kapasi, AA; Mattana, J; Singhal, PC | 1 |
| Lawental, E | 1 |
| Borg, L; Carson, RE; Eckelman, WC; Herscovitch, P; Ho, A; Kling, MA; Kreek, MJ; Matochik, JA; Rice, KC; Schluger, J; Zametkin, A | 1 |
| Boto, I; Gomes, PC; Henriques, V; Macedo, TR; Morgadinho, MT; Nunes, SV; Pacheco, F; Pinto, CM; Ramalheira, C; Relvas, J; Ruis, GR; Vale, LL; Ventura, M | 1 |
| Bisaga, A; Popik, P; Radomska, M | 1 |
| Christakopoulou, I; Ilias, I; Kakoulas, I; Katsadoros, K | 1 |
| Burakov, AM; Didenko, TY; Krupitsky, EM; Masalov, DV; Romanova, TN; Woody, G; Zvartau, EE | 1 |
| Bristow, K; Clark, N; Meek, R | 1 |
| Boyce, SH; Quigley, MA | 1 |
| Xu, K; Yang, G; Zhou, W | 1 |
| Blumenreich, GA | 1 |
| Stimmel, B | 1 |
| Brewer, C; Hulse, GK; O'Neill, G; Pereira, C | 1 |
| Collins, ED; Comer, SD; Fischman, MW; Kerrigan, JH; Kleber, HD; Nuwayser, ES | 1 |
| Heilig, M | 2 |
| Tedeschi, M | 1 |
| Asplund, K; Jonsson, E | 1 |
| Hulse, GK; O'Neill, G | 1 |
| Ritter, AJ | 1 |
| Alvarez, CE; Bascarán, MT; Bobes, J; Brewer, C; Carreño, JE; San Narciso, GI; Sánchez del Río, J | 1 |
| Grabowski, J; Greenstein, R; McLellan, AT; O'Brien, CP; Ternes, J | 1 |
| Chipkin, RE; Rosecrans, JA | 1 |
| Mello, NK; Mendelson, JH | 4 |
| Julius, DA | 2 |
| Ling, W | 1 |
| Callahan, EJ; Glazer, M; Liberman, RP; Rawson, RA | 1 |
| Ellingboe, J; Kuehnle, J; Mello, NK; Mendelson, JH | 1 |
| Grabowski, J; Greenstein, R; Long, M; O'Brien, CP; Steinberg-Donato, S; Ternes, J | 2 |
| Altman, JL; Meyer, RE; Mirin, SM | 1 |
| Altman, JL; McNamee, HB; Meyer, RE; Mirin, SM | 3 |
| Randall, M; Rawlins, M | 1 |
| Barrington, C; Greenberg, I; Meyer, R; Mirin, S; Randall, R | 1 |
| Goldstein, A | 3 |
| Julius, D | 1 |
| Wikler, A | 2 |
| Kestenbaum, RS; Resnick, RB; Thomas, MA; Washton, AM | 1 |
| Cho, D; James, B; Mallya, A; Pevnick, J; Reker, D; Volavka, J | 1 |
| Black, R; Hersch, RG; Lewis, DC; Mayer, J | 1 |
| Brotman, R; Remine, DC; Suffet, F; Taleporos, E | 1 |
| Brahen, LS; Capone, T; Heller, RC; Landy, HJ; Lewis, MJ; Linden, SL | 1 |
| Charuvastra, VC; Jarvik, ME; Sideroff, SI | 1 |
| Landsberg, R; Taintor, Z; Wicks, N | 1 |
| Arias, R; Callahan, E; Glazer, M; McCleave, B; Rawson, R | 1 |
| Kaim, SC | 1 |
| Curran, S; Savage, C | 1 |
| Blakis, M; Haas, N; Holmes, E; Ling, W; Litaker, M | 1 |
| Crawford, J; De Gracia, C; Nelkupa, JV; Parwatikar, S | 1 |
| Kestenbaum, RS; Poole, D; Resnick, RB; Washton, A | 1 |
| Brahen, LS; Capone, T; Desiderio, D; Wiechert, V | 1 |
| Swanson, DA | 1 |
| McNamee, HB; Meyer, RE; Mirin, SM | 1 |
| Freedman, AM; Kestenbaum, RS; Resnick, RB; Volavka, J | 1 |
| Jaffe, J | 1 |
| Aronoff, M; Hough, G; Kauders, F; Kestenbaum, R; Lonborg, G; Resnick, R; Washton, A | 1 |
| Martin, WR | 1 |
| Mulé, SJ; Verebey, K | 1 |
| Greenstein, RA; Mintz, J; O'Brien, CP; Woody, GE | 1 |
| Lewis, DC | 1 |
| Schecter, A | 1 |
| Kauders, F; Schecter, A | 1 |
| Brahen, LS | 1 |
| Stewart, J; Wise, RA | 1 |
| Senft, RA | 1 |
| Kleber, HD; Kosten, TR; Morgan, C | 1 |
| Cami, J; Olle, JM; Peri, JM; Pomarol, G; San, L | 1 |
| Charney, DS; Kleber, HD; Kosten, TR; Krystal, JH; Morgan, CH; Price, LH | 1 |
| Marra, R; Schifano, F | 1 |
| Schuster, CR; Snyder, M | 1 |
| Cammera, P; Griffiths, W; Swift, RM | 1 |
| Brogden, RN; Gonzalez, JP | 1 |
| Eriksson, I; McLellan, AT; Nyberg, F; O'Brien, CP; Terenius, LY | 1 |
| Van Ree, JM | 1 |
| Kleber, HD; Kosten, TR; Kreek, MJ; Ragunath, J | 2 |
| Cugurra, F | 1 |
| Gaspari, J; Kleber, HD; Kosten, TR; Topazian, M | 1 |
| Meyer, RE | 1 |
| Areso, P; García-Sevilla, JA; Giralt, MT; Gutiérrez, M; Oliveros, RG; Ulibarri, I | 1 |
| Brahen, LS; Capone, DM; Capone, TJ | 1 |
| Williams, A | 1 |
| Santos, EF | 1 |
| Agren, H | 1 |
| Rimailho, A | 1 |
| Friedman, JG; Grossman, DJ; Schecter, AJ | 1 |
27 review(s) available for naltrexone and Heroin Abuse
| Article | Year |
|---|---|
Adverse effects of subcutaneous, drug-releasing implants for the treatment of opioid drug addiction.
Topics: Adult; Device Removal; Drug Eruptions; Drug Implants; Heroin; Heroin Dependence; Humans; Male; Naltrexone; Prostheses and Implants | 2017 |
Rapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of the liter
Topics: Administration, Intravenous; Adult; Anesthesia, General; Bioethical Issues; Diabetes Complications; Epilepsy; Heroin Dependence; Humans; Hypnotics and Sedatives; Male; Naltrexone; Narcotic Antagonists; Remission Induction; Substance Withdrawal Syndrome | 2014 |
[Therapy in heroin addiction].
Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics, Opioid; Buprenorphine; Euphoria; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment | 2014 |
A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
Topics: Buprenorphine; Heroin Dependence; HIV Infections; Humans; International Cooperation; Methadone; Naltrexone; Narcotic Antagonists; Patient Care; Prisoners; Prisons | 2009 |
Long-acting depot formulations of naltrexone for heroin dependence: a review.
Topics: Delayed-Action Preparations; Drug Implants; Heroin Dependence; Humans; Injections, Intramuscular; Medication Adherence; Naltrexone; Narcotic Antagonists; Secondary Prevention | 2010 |
Heroin anticraving medications: a systematic review.
Topics: Buprenorphine; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2010 |
Opioid dependence.
Topics: Analgesics, Opioid; Buprenorphine; Evidence-Based Medicine; Heroin Dependence; Humans; Incidence; Methadone; Naltrexone; Opioid-Related Disorders | 2009 |
Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.
Topics: Delayed-Action Preparations; Drug Implants; Female; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prisoners; Time Factors | 2014 |
A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence.
Topics: Controlled Clinical Trials as Topic; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Pharmacologic treatments for heroin and cocaine dependence.
Topics: Buprenorphine; Clonidine; Cocaine-Related Disorders; Comorbidity; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics | 2003 |
Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.
Topics: Acute Disease; Adult; Delayed-Action Preparations; Drug Implants; Hepatitis B; Hepatitis C; Heroin Dependence; Humans; Liver Function Tests; Male; Naltrexone; Narcotic Antagonists | 2004 |
Research on naltrexone in the criminal justice system.
Topics: Criminal Law; Forensic Psychiatry; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; United States | 2006 |
[Prevention of heroin reabuse--value of naltrexone].
Topics: Heroin Dependence; Humans; Israel; Naltrexone; Recurrence | 1993 |
[Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Topics: Alcoholism; Delayed-Action Preparations; Follow-Up Studies; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Treatment Outcome | 1996 |
An addict who wants to detoxify.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clonidine; Heroin Dependence; Humans; Jaundice; Male; Naltrexone; Needle Sharing; Serologic Tests | 1998 |
Pharmacologic treatment of heroin-dependent patients.
Topics: Analgesics, Opioid; Buprenorphine; Counseling; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Physician's Role; Substance Withdrawal Syndrome | 2000 |
[Contemporary methods in pharmacotherapy in the opiate dependent treatment].
Topics: Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Heroin Dependence; Humans; Inactivation, Metabolic; Methadone; Naltrexone; Narcotic Antagonists; Narcotics | 2000 |
Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose.
Topics: Depressive Disorder; Drug Overdose; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Risk Factors | 2002 |
NIDA's naltrexone research program.
Topics: Clinical Trials as Topic; Conditioning, Psychological; Cyclazocine; Drug Evaluation; Euphoria; Heroin; Heroin Dependence; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Research; Research Support as Topic; United States; United States Substance Abuse and Mental Health Services Administration | 1976 |
Methadone maintenance and narcotic blocking drugs. Appendix.
Topics: Administration, Oral; Cyclazocine; Drug Tolerance; Heroin Dependence; Humans; Injections, Subcutaneous; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Research; Substance Withdrawal Syndrome | 1977 |
Evolution of the National Academy of Sciences study of naltrexone.
Topics: Academies and Institutes; Clinical Trials as Topic; Cyclazocine; Drug Evaluation; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Research Design; Research Support as Topic | 1976 |
Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.
Topics: Animals; Heroin; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Receptors, Opioid | 1988 |
[Naltrexone, opiate antagonist, in the therapy of drug dependence].
Topics: Heroin Dependence; Humans; Naltrexone | 1988 |
Clinical investigations of drug effects in women.
Topics: Buprenorphine; Cocaine; Desipramine; Female; Heroin Dependence; Humans; Male; Naltrexone; Opioid-Related Disorders; Sex Factors; Substance-Related Disorders | 1986 |
Naltrexone: useful tool in the treatment of heroin users: a review of the literature.
Topics: Animals; Behavior Therapy; Heroin Dependence; Humans; Naltrexone; Prognosis; Reinforcement, Social | 1986 |
Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
Topics: Adrenergic Fibers; Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; Clonidine; Dextropropoxyphene; Drug Therapy, Combination; Heroin Dependence; Humans; Locus Coeruleus; Methadone; Morphine; Naltrexone; Narcotics; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1986 |
Behavioral pharmacology of buprenorphine.
Topics: Adult; Animals; Buprenorphine; Conditioning, Operant; Eating; Heroin Dependence; Humans; Macaca; Male; Methadone; Morphinans; Naltrexone; Opioid-Related Disorders; Reinforcement, Psychology; Self Administration | 1985 |
80 trial(s) available for naltrexone and Heroin Abuse
| Article | Year |
|---|---|
Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers.
Topics: Adult; Behavior Therapy; Buprenorphine; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Misuse | 2015 |
Baseline characteristics of patients predicting suitability for rapid naltrexone induction.
Topics: Administration, Oral; Adult; Buprenorphine; Clonidine; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Selection; Prognosis | 2015 |
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.
Topics: Adult; Buprenorphine; Counseling; Double-Blind Method; Heroin Dependence; HIV Infections; Humans; Malaysia; Naltrexone; Narcotic Antagonists; Recurrence; Risk-Taking; Treatment Outcome | 2008 |
Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Middle Aged; Motivation; Naltrexone; Narcotic Antagonists; Norway; Secondary Prevention; Treatment Outcome; Young Adult | 2009 |
Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
Topics: Adult; Buprenorphine; Cognition Disorders; Female; Heroin Dependence; Humans; Male; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Psychomotor Performance; Verbal Learning | 2009 |
Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Topics: Administration, Oral; Adult; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Recurrence; Substance Abuse Detection; Tablets; Treatment Outcome | 2009 |
Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone.
Topics: Adult; Delayed-Action Preparations; Double-Blind Method; Drug Implants; Drug-Seeking Behavior; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Compliance; Recurrence; Risk Factors; Tablets; Treatment Outcome | 2010 |
[Naltrexone and fluoxetine for maintenance of remission in patients with heroin addiction: a double-blind randomized placebo-controlled trial].
Topics: Adolescent; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Placebos; Remission Induction; Selective Serotonin Reuptake Inhibitors; Young Adult | 2010 |
Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.
Topics: Adult; Amphetamine-Related Disorders; Double-Blind Method; Drug Implants; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; Treatment Outcome; Unsafe Sex | 2012 |
Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.
Topics: Administration, Oral; Adolescent; Adult; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Implants; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Russia; Secondary Prevention; Substance Abuse Detection; Young Adult | 2012 |
Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
Topics: Administration, Oral; Adult; Baltimore; Cocaine-Related Disorders; Conditioning, Operant; Female; Heroin Dependence; Humans; Male; Medication Adherence; Middle Aged; Naltrexone; Narcotic Antagonists; Odds Ratio; Opioid-Related Disorders; Patient Acceptance of Health Care; Personality Assessment; Psychometrics; Rehabilitation, Vocational; Risk-Taking; Sheltered Workshops; Substance Abuse Detection; Substance Abuse, Intravenous | 2012 |
Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
Topics: Acquired Immunodeficiency Syndrome; Buprenorphine; Cost-Benefit Analysis; Heroin Dependence; Humans; Malaysia; Naltrexone; Risk Factors; Risk-Taking; Treatment Outcome | 2012 |
Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Data Collection; Drug Implants; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Randomized Controlled Trials as Topic; Self Report | 2013 |
A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
Topics: Adrenergic alpha-Agonists; Adult; Anesthesia, General; Clonidine; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Risk Factors; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 2002 |
Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits.
Topics: Adult; Blood Pressure; Comorbidity; Epinephrine; Heart Rate; Heroin Dependence; Humans; Hydrocortisone; Male; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Norepinephrine; Personality Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2003 |
[Pharmacotherapy in heroin addiction: pharmacological approaches to remission stabilization and recurrence prevention].
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Double-Blind Method; Drug Therapy, Combination; Heroin Dependence; Humans; Mood Disorders; Naltrexone; Narcotic Antagonists; Patient Compliance; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2003 |
Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.
Topics: Adolescent; Adult; Female; Heroin; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Severity of Illness Index; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2003 |
Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
Topics: Adult; Ambulatory Care; Biological Availability; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Drug Administration Schedule; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Premedication; Psychotherapy; Spain; Treatment Outcome | 2003 |
Add-on gabapentin in the treatment of opiate withdrawal.
Topics: Acetates; Adult; Amines; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Heroin; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Narcotics; Recurrence; Substance Withdrawal Syndrome | 2004 |
Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD)--correlation with neurophysiological parameters--.
Topics: Acetates; Adult; Amines; Anesthesia; Anesthetics, Intravenous; Cyclohexanecarboxylic Acids; Electric Stimulation; Evoked Potentials, Somatosensory; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Heroin Dependence; Hormone Antagonists; Humans; Magnesium; Male; Median Nerve; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Potassium; Propofol; Restless Legs Syndrome; Somatostatin; Substance Withdrawal Syndrome; Water-Electrolyte Balance | 2004 |
Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
Topics: Adult; Analysis of Variance; Combined Modality Therapy; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Pilot Projects; Psychotherapy; Russia | 2004 |
Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
Topics: Adult; Body Mass Index; Cohort Studies; Delayed-Action Preparations; Drug Administration Schedule; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Retrospective Studies; Time Factors | 2004 |
Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants.
Topics: Adult; Body Mass Index; Delayed-Action Preparations; Drug Administration Schedule; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Retrospective Studies | 2004 |
A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone | 2004 |
Naltrexone maintenance for heroin dependence: uptake, attrition and retention.
Topics: Adult; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Patient Compliance | 2004 |
A randomized control trial of group counseling in a naltrexone treatment program.
Topics: Adult; Analysis of Variance; Australia; Cognitive Behavioral Therapy; Combined Modality Therapy; Counseling; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Psychotherapy, Group; Secondary Prevention; Time Factors | 2004 |
Opioid antagonist detoxification under anaesthesia versus traditional clonidine detoxification combined with an additional week of psychosocial support: a randomised clinical trial.
Topics: Adult; Algorithms; Analgesics; Anesthesia, General; Clonidine; Drug Administration Schedule; Female; Heroin Dependence; Hospitals, Psychiatric; Hospitals, Teaching; Humans; Inactivation, Metabolic; Male; Naltrexone; Narcotic Antagonists; Prospective Studies; Recurrence; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 2006 |
A new approach to preventing relapse in opiate addicts: a psychometric evaluation.
Topics: Administration, Oral; Adult; Affect; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Outcome and Process Assessment, Health Care; Personality Inventory; Psychometrics; Secondary Prevention; Substance Withdrawal Syndrome | 2006 |
Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Topics: Adult; Anesthesia, General; Buprenorphine; Clonidine; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2005 |
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Cocaine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; Humans; Injections, Subcutaneous; Male; Methadone; Middle Aged; Naltrexone; Narcotics; Placebos; Secondary Prevention; Substance Abuse Detection; Treatment Outcome | 2006 |
Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence.
Topics: Adult; Depression; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists | 2006 |
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin.
Topics: Adult; Affect; Cardiovascular System; Choice Behavior; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Heroin; Heroin Dependence; Humans; Liver; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Pupil; Self Administration; Time Factors; Token Economy | 2006 |
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heroin; Heroin Dependence; HIV Infections; Humans; Male; Naltrexone; Narcotic Antagonists; Psychotherapy; Russia; Secondary Prevention; Substance Abuse, Intravenous; Substance Withdrawal Syndrome | 2006 |
Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
Topics: Behavior Therapy; Combined Modality Therapy; Heroin Dependence; Humans; Inpatients; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Compliance; Treatment Outcome | 2006 |
Mental health outcomes following naltrexone implant treatment for heroin-dependence.
Topics: Administration, Oral; Adolescent; Adult; Databases, Factual; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Retrospective Studies; Risk Factors; Treatment Outcome; Western Australia | 2007 |
Implications of cannabis use and heavy alcohol use on HIV drug risk behaviors in Russian heroin users.
Topics: Adult; Alcohol Drinking; Cannabis; Disease Outbreaks; Female; Heroin Dependence; HIV Infections; Humans; Male; Naltrexone; Risk-Taking; Russia; Sexual Behavior; Treatment Outcome | 2008 |
Blood naltrexone levels over time following naltrexone implant.
Topics: Adult; Alcoholism; Confidence Intervals; Dose-Response Relationship, Drug; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Retrospective Studies; Time Factors | 2008 |
Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence.
Topics: Adult; Affect; Asparagine; Buprenorphine; DNA Mutational Analysis; Drug Interactions; Enzyme Inhibitors; Female; Heroin Dependence; Humans; Hypothalamo-Hypophyseal System; Male; Metyrapone; Middle Aged; Naltrexone; Narcotic Antagonists; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Time Factors | 2008 |
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
Topics: Adult; Affect; Arousal; Butorphanol; Diuresis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Naltrexone; Narcotic Antagonists; Narcotics; Perception; Premedication; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |
Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Outcome and Process Assessment, Health Care; Placebos; Substance Withdrawal Syndrome | 1983 |
Effects of heroin self-administration on cigarette smoking.
Topics: Adult; Buprenorphine; Heroin Dependence; Humans; Male; Naltrexone; Self Administration; Smoking; Time Factors | 1980 |
Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison.
Topics: Adolescent; Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Middle Aged; Naloxone; Naltrexone | 1981 |
Operant analysis of human heroin self-administration and the effects of naltrexone.
Topics: Adult; Conditioning, Operant; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Placebos; Self Administration | 1981 |
Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts.
Topics: Adult; Arousal; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Double-Blind Method; Heroin; Heroin Dependence; Humans; Malaysia; Male; Naltrexone; Neurologic Examination; Receptors, Opioid; Substance Abuse, Intravenous | 1994 |
The efficacy of naltrexone in preventing reabuse of heroin after detoxification.
Topics: Adult; Double-Blind Method; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Substance-Related Disorders | 1994 |
Buprenorphine for benzodiazepine-abusing heroin addicts.
Topics: Administration, Sublingual; Benzodiazepines; Buprenorphine; Heroin Dependence; Humans; Methadone; Naltrexone; Substance-Related Disorders | 1994 |
Hostility in heroin abusers subtypes: fluoxetine and naltrexone treatment.
Topics: Adult; Aggression; Antidepressive Agents, Second-Generation; Fenfluramine; Fluoxetine; Heroin Dependence; Hostility; Humans; Male; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Psychiatric Status Rating Scales; Treatment Outcome | 1995 |
Three methods of opioid detoxification in a primary care setting. A randomized trial.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Buprenorphine; Clonidine; Double-Blind Method; Drug Therapy, Combination; Female; Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Primary Health Care; Substance Withdrawal Syndrome | 1997 |
Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success.
Topics: Adult; Conscious Sedation; Critical Care; Heroin Dependence; Humans; Inactivation, Metabolic; Infusions, Intravenous; Length of Stay; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Recurrence; Substance Withdrawal Syndrome; Treatment Failure | 1997 |
A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.
Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors | 1998 |
Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure.
Topics: Acute Kidney Injury; Adult; Anesthesia; Codeine; Female; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Respiratory Insufficiency; Substance Withdrawal Syndrome; Thyroid Hormones | 1999 |
Improvement in naltrexone treatment compliance with contingency management.
Topics: Adult; Analysis of Variance; Behavior Therapy; Chi-Square Distribution; Female; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Prospective Studies; Substance Abuse Detection; Token Economy; Treatment Outcome | 1999 |
A pilot study of naltrexone-accelerated detoxification in opioid dependence.
Topics: Adolescent; Adult; Analgesics; Anti-Anxiety Agents; Clonidine; Conscious Sedation; Female; Flunitrazepam; Heroin; Heroin Dependence; Hormones; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Octreotide; Pilot Projects; Substance Withdrawal Syndrome; Time Factors | 1999 |
Naltrexone shortened opioid detoxification with buprenorphine.
Topics: Adult; Analgesics; Area Under Curve; Buprenorphine; Clonidine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Heroin; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 1999 |
Clinical experience with naltrexone maintenance in a hospital drug and alcohol outpatient setting.
Topics: Alcoholism; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Outpatient Clinics, Hospital; Patient Selection | 1999 |
Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Clonidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; GABA Agents; Heroin Dependence; Humans; Inactivation, Metabolic; Ketoprofen; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Oxazepam; Patient Compliance; Substance Withdrawal Syndrome; Treatment Outcome | 2000 |
An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence.
Topics: Administration, Sublingual; Adult; Affect; Buprenorphine; Drug Therapy, Combination; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Dropouts; Psychiatric Status Rating Scales; Pupil; Receptors, Opioid, kappa; Recurrence; Substance Abuse Detection; Treatment Outcome | 2000 |
Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
Topics: Adult; Blood Pressure; Clonidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Neurologic Examination; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 2000 |
Plasma catecholamines during an ultrarapid heroin detoxification.
Topics: Adult; Analysis of Variance; Catecholamines; Drug Administration Routes; Drug Therapy, Combination; Female; Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Naloxone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Systole; Treatment Outcome | 2000 |
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans.
Topics: Adult; Affect; Analysis of Variance; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dose-Response Relationship, Drug; Heroin; Heroin Dependence; Humans; Injections, Intravenous; Male; Naltrexone; Narcotic Antagonists; Narcotics; Pupil | 2002 |
24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
Topics: Administration, Oral; Adult; Aftercare; Anti-Anxiety Agents; Benzodiazepines; Clonidine; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Home Care Services, Hospital-Based; Humans; Male; Methadone; Naltrexone; Octreotide; Opioid-Related Disorders; Patient Admission; Substance Withdrawal Syndrome; Time Factors | 2002 |
Limitations of an extinction approach to narcotic antagonist treatment.
Topics: Aftercare; Age Factors; Clinical Trials as Topic; Conditioning, Psychological; Drug Administration Schedule; Extinction, Psychological; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Research Design; Self Administration; Time Factors | 1976 |
NIDA's naltrexone research program.
Topics: Clinical Trials as Topic; Conditioning, Psychological; Cyclazocine; Drug Evaluation; Euphoria; Heroin; Heroin Dependence; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Research; Research Support as Topic; United States; United States Substance Abuse and Mental Health Services Administration | 1976 |
Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Heroin; Heroin Dependence; Humans; Male; Methadone; Motivation; Naloxone; Naltrexone; Patient Compliance; Placebos; Research Design; Social Adjustment | 1978 |
EEG and other effects of naltrexone and heroin in man.
Topics: Auditory Threshold; Circadian Rhythm; Electroencephalography; Electrooculography; Heroin; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Time Factors | 1979 |
Controlled clinical study of naltrexone side effects comparing first-day doses and maintenance regimens.
Topics: Administration, Oral; Adolescent; Adult; Double-Blind Method; Drug Administration Schedule; Heroin Dependence; Humans; Male; Middle Aged; Naloxone; Naltrexone; Placebos; Self-Assessment | 1978 |
Experiences with Naltrexone in Buffalo.
Topics: Administration, Oral; Clinical Trials as Topic; Consumer Behavior; Female; Heroin Dependence; Hospitalization; Humans; Male; Motivation; Naloxone; Naltrexone; New York; Outpatient Clinics, Hospital; Patient Dropouts | 1975 |
Narcotic antagonists: naltrexone progress report: introduction.
Topics: Clinical Trials as Topic; Drug Evaluation; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Research | 1976 |
Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy.
Topics: Adult; Behavior Therapy; Black or African American; Black People; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Employment; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Narcotics; Patient Compliance; Spain; Students | 1976 |
Evolution of the National Academy of Sciences study of naltrexone.
Topics: Academies and Institutes; Clinical Trials as Topic; Cyclazocine; Drug Evaluation; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Research Design; Research Support as Topic | 1976 |
Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Patient Acceptance of Health Care; Patient Dropouts; Substance-Related Disorders; Time Factors | 1976 |
Naltrexone in methadone maintenance patients electing to become "drug free".
Topics: Adult; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Patient Dropouts; Research Design | 1976 |
Factors influencing success in an antagonistic treatment program.
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Patient Compliance; Patient Dropouts; Research Design | 1976 |
Naltrexone and cyclazocine. A controlled treatment study.
Topics: Administration, Oral; Adult; Cyclazocine; Double-Blind Method; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Placebos; Self-Assessment | 1977 |
Treatment of heroin addicts using buprenorphine.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Neurologic Examination; Substance Withdrawal Syndrome | 1991 |
Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone | 1991 |
Opioid antagonist challenges in buprenorphine maintained patients.
Topics: Administration, Sublingual; Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Infusions, Intravenous; Male; Methadone; Naloxone; Naltrexone; Substance Withdrawal Syndrome | 1990 |
Nontolerance to the opioid antagonism of naltrexone.
Topics: Adult; Arousal; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Tolerance; Euphoria; Female; Heart Rate; Heroin Dependence; Humans; Male; Middle Aged; Morphine; Naloxone; Naltrexone; Receptors, Opioid | 1985 |
Conditioning phenomena and the problem of relapse in opioid addicts and alcoholics.
Topics: Alcoholism; Clinical Trials as Topic; Conditioning, Psychological; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Naltrexone; Recurrence | 1988 |
Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
Topics: Adrenergic Fibers; Animals; Antidepressive Agents, Tricyclic; Brain; Clinical Trials as Topic; Clonidine; Dextropropoxyphene; Drug Therapy, Combination; Heroin Dependence; Humans; Locus Coeruleus; Methadone; Morphine; Naltrexone; Narcotics; Norepinephrine; Rats; Substance Withdrawal Syndrome | 1986 |
195 other study(ies) available for naltrexone and Heroin Abuse
| Article | Year |
|---|---|
Severe opioid withdrawal precipitated by Vivitrol®.
Topics: Adult; Emergency Medical Services; Female; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2018 |
A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.
Topics: Adult; Buprenorphine; Delayed-Action Preparations; Feasibility Studies; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Outpatients; Recurrence; Substance Withdrawal Syndrome; Young Adult | 2020 |
Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.
Topics: Alcoholism; Antisocial Personality Disorder; Buprenorphine; Heroin Dependence; Humans; Male; Medication Errors; Middle Aged; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2017 |
High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns.
Topics: Adult; Dose-Response Relationship, Drug; England; Heroin Dependence; Humans; Injections; Likelihood Functions; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Acceptance of Health Care; Prisoners; Young Adult | 2018 |
Impact of opioid pharmacotherapy on arterial stiffness and vascular ageing: cross-sectional and longitudinal studies.
Topics: Adult; Aging; Blood Vessels; Buprenorphine; Cross-Sectional Studies; Endothelium, Vascular; Female; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Phenotype; Pulse Wave Analysis; Regression Analysis; Vascular Stiffness | 2013 |
Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake.
Topics: Animals; Anxiety; Catheterization; Conditioning, Operant; Enkephalins; Heroin Dependence; Immunohistochemistry; Male; Motivation; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Protein Precursors; Rats; Rats, Wistar; Receptors, Opioid, kappa; Reinforcement Schedule; Self Administration; Substance Withdrawal Syndrome | 2013 |
'Miracle cure' or 'liquid handcuffs': reporting on naltrexone and methadone in the Australian print media.
Topics: Australia; Heroin Dependence; Humans; Mass Media; Methadone; Naltrexone; Newspapers as Topic; Opiate Substitution Treatment; Public Opinion; Treatment Outcome | 2014 |
Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
Topics: Adult; Anhedonia; Corpus Striatum; Delayed-Action Preparations; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Plasma Membrane Transport Proteins; Female; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals; Substance Abuse Detection; Tomography, Emission-Computed, Single-Photon; Tropanes | 2015 |
Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.
Topics: Adult; Brain; Craving; Cues; Female; Heroin Dependence; Humans; Magnetic Resonance Imaging; Male; Naltrexone; Narcotic Antagonists; Patient Compliance | 2015 |
Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County.
Topics: Adult; Craving; Delayed-Action Preparations; Female; Heroin Dependence; Humans; Los Angeles; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Abuse, Intravenous | 2016 |
Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Disease Models, Animal; Fluoxetine; Grooming; Heroin; Heroin Dependence; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Social Behavior; Time; Treatment Outcome | 2017 |
Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands.
Topics: Heroin; Heroin Dependence; Humans; Naltrexone; Netherlands | 2016 |
Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
Topics: Adult; Ambulatory Care; Employment, Supported; Female; Heroin Dependence; Humans; Male; Medication Adherence; Middle Aged; Motivation; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic | 2017 |
A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
Topics: Buprenorphine; Drug Therapy, Combination; Female; Heroin Dependence; History, 19th Century; History, 20th Century; Humans; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Recurrence; Self-Help Groups; United States | 2008 |
Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
Topics: Adolescent; Analgesics, Opioid; Delayed-Action Preparations; Female; Heroin Dependence; Humans; Metabolic Clearance Rate; Naltrexone; Narcotic Antagonists; Oxycodone; Patient Acceptance of Health Care; Substance Withdrawal Syndrome | 2008 |
Substitution treatment in Malaysia.
Topics: Buprenorphine; Drug Utilization; Heroin Dependence; Humans; Malaysia; Methadone; Naltrexone; Patient Compliance; Pilot Projects; Policy Making | 2008 |
Unplanned admissions to two Sydney public hospitals after naltrexone implants.
Topics: Causality; Drug Implants; Heroin Dependence; Hospitals, Public; Humans; Naltrexone; Narcotic Antagonists; New South Wales; Substance Withdrawal Syndrome | 2008 |
Alleviation of both binge eating and sexual dysfunction with naltrexone.
Topics: Alcoholism; Antidepressive Agents; Bulimia; Child; Child Abuse; Depression; Female; Heroin Dependence; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Sex Work; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Stress Disorders, Post-Traumatic | 2008 |
Unplanned admissions to two Sydney public hospitals after naltrexone implants.
Topics: Drug Implants; Heroin Dependence; Hospitals, Public; Humans; Naltrexone; Narcotic Antagonists; Research Design; Substance Withdrawal Syndrome | 2008 |
Unplanned admissions to two Sydney public hospitals after naltrexone implants.
Topics: Heroin Dependence; Hospitals, Public; Humans; Inactivation, Metabolic; Naltrexone; Narcotic Antagonists; Research Design; Substance Withdrawal Syndrome | 2008 |
Unplanned admissions to two Sydney public hospitals after naltrexone implants.
Topics: Drug Implants; Gastrointestinal Agents; Heroin Dependence; Hospitals, Public; Humans; Naltrexone; Narcotic Antagonists; New South Wales; Octreotide; Substance Withdrawal Syndrome | 2008 |
Effects of training and withdrawal periods on heroin seeking induced by conditioned cue in an animal of model of relapse.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Cues; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Exploratory Behavior; Heroin; Heroin Dependence; Male; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Secondary Prevention; Self Administration; Substance Withdrawal Syndrome | 2009 |
Opiate agonist treatment for addiction.
Topics: Buprenorphine; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Time Factors | 2008 |
Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Female; Heroin Dependence; Humans; Inpatients; Male; Middle Aged; Models, Statistical; Naltrexone; Narcotic Antagonists; Patient Compliance; Treatment Outcome | 2009 |
Naltrexone implants.
Topics: Drug Implants; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Patient Selection; Withholding Treatment | 2010 |
Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user.
Topics: Analgesics, Opioid; Female; Heroin Dependence; Humans; Ileus; Injections, Subcutaneous; Middle Aged; Naltrexone; Narcotic Antagonists; Postoperative Complications; Quaternary Ammonium Compounds | 2010 |
Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
Topics: Adult; Australia; Diagnosis, Dual (Psychiatry); Drug Implants; Female; Heroin Dependence; Hospitalization; Humans; Longitudinal Studies; Male; Mental Disorders; Methadone; Naltrexone; Opiate Substitution Treatment; Prevalence | 2011 |
Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study.
Topics: Adolescent; Adult; Aged; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Multivariate Analysis; Naltrexone; Narcotic Antagonists; Patient Acceptance of Health Care; Psychotherapy; Social Support; Substance Abuse Treatment Centers; Treatment Outcome | 2010 |
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment.
Topics: Administration, Oral; Adult; Cognitive Behavioral Therapy; Delayed-Action Preparations; Female; Heroin Dependence; Humans; Injections, Intramuscular; Male; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic | 2010 |
Costs of addressing heroin addiction in Malaysia and 32 comparable countries worldwide.
Topics: Buprenorphine; Cambodia; Cost of Illness; Drug Costs; Gross Domestic Product; Health Care Costs; Heroin Dependence; Humans; Laos; Malaysia; Naltrexone; Narcotic Antagonists | 2012 |
Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.
Topics: Adult; Analysis of Variance; Brain; Cues; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Heroin Dependence; Humans; Linear Models; Magnetic Resonance Imaging; Male; Naltrexone; Narcotic Antagonists; Oxygen; Photic Stimulation; Secondary Prevention | 2014 |
Is sustained release natrexone an option for heroin-dependent pregnant women?
Topics: Animals; Female; Fetus; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Rats; Research Design | 2013 |
Naltrexone in the treatment of opioid-dependent pregnant women: common ground.
Topics: Animals; Brain; Buprenorphine; Ethics, Medical; Female; Fetal Development; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Research Design | 2013 |
Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.
Topics: Adult; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Implants; Half-Life; Heroin; Heroin Dependence; Humans; Male; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Patient Dropouts | 2002 |
Using naltrexone implants in the management of the pregnant heroin user.
Topics: Adult; Drug Implants; Female; Heroin Dependence; Humans; Infant, Newborn; Male; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2002 |
Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.
Topics: Adult; Buprenorphine; Conscious Sedation; Family Practice; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Premedication; Recurrence; Substance Withdrawal Syndrome; Time Factors; Vomiting | 2003 |
Experiences with an outpatient relapse program (community reinforcement approach) combined with naltrexone in the treatment of opioid-dependence: effect on addictive behaviors and the predictive value of psychiatric comorbidity.
Topics: Adult; Combined Modality Therapy; Community Mental Health Services; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Patient Care Team; Patient Compliance; Patient Dropouts; Psychotherapy; Reinforcement, Psychology; Secondary Prevention | 2003 |
[Use of naltrexone in the treatment of young drug addicts].
Topics: Adult; Chemotherapy, Adjuvant; Drug Monitoring; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2003 |
Effect of innappropriate naltrexone use in a heroin misuser.
Topics: Adult; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Psychomotor Agitation; Substance Withdrawal Syndrome | 2003 |
Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Topics: Adult; Cohort Studies; Drug Administration Routes; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Prevalence; Prostheses and Implants; Recurrence | 2003 |
A pilot study to assess the impact of naltrexone implant on accidental opiate overdose in 'high-risk' adolescent heroin users.
Topics: Accidents; Administration, Oral; Adolescent; Adolescent Behavior; Adult; Drug Overdose; Female; Follow-Up Studies; Heroin Dependence; Hospitalization; Humans; Infusion Pumps, Implantable; Male; Naltrexone; Narcotic Antagonists; Pilot Projects; Risk-Taking; Time Factors | 2003 |
Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses.
Topics: Adult; Australia; Cohort Studies; Drug Overdose; Female; Heroin; Heroin Dependence; Humans; Male; Morphine; Naltrexone; Narcotic Antagonists; Registries; Retrospective Studies; Time Factors | 2003 |
Opioid partial agonist effects of 3-O-methylnaltrexone in rhesus monkeys.
Topics: Adenylyl Cyclases; Animals; Cocaine; Discrimination Learning; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Heroin; Heroin Dependence; Macaca mulatta; Male; Morphine; Morphine Derivatives; Naltrexone; Narcotics; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Self Administration | 2004 |
[Detoxification in withdrawal state in methadone maintenance patients].
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Data Interpretation, Statistical; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome | 2003 |
Naltrexone implant and blood naltrexone levels over pregnancy.
Topics: Adult; Drug Implants; Female; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy Complications | 2003 |
Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
Topics: Australia; Drug Implants; Female; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2004 |
Orthoptic status before and immediately after heroin detoxification.
Topics: Accommodation, Ocular; Adolescent; Adult; Convergence, Ocular; Diplopia; Eye Movements; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotics; Refractive Errors; Vision, Binocular; Visual Acuity | 2004 |
Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.
Topics: Adolescent; Adult; Ambulatory Care; Analgesics, Opioid; Anesthesia; Buprenorphine; Female; Heroin Dependence; Hospitalization; Humans; Hypnotics and Sedatives; Inactivation, Metabolic; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2005 |
Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants.
Topics: Adult; Cohort Studies; Drug Implants; Drug Overdose; Emergency Service, Hospital; Female; Heroin Dependence; Hospitalization; Humans; Male; Medical Record Linkage; Naltrexone; Narcotics; Opioid-Related Disorders; Patient Admission; Prospective Studies | 2005 |
Blame the counselling, not the implant. A response to Oliver, Horspool & Keen (2005).
Topics: Clinical Competence; Counseling; Drug Implants; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists | 2005 |
A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Chi-Square Distribution; Cost-Benefit Analysis; Female; Heroin Dependence; Humans; Hypnotics and Sedatives; Male; Methadone; Naltrexone; Narcotic Antagonists | 2006 |
Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat.
Topics: Animals; Ethanol; Heroin; Heroin Dependence; Male; Methadone; Microsomes, Liver; Morphine; Morphine Derivatives; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2005 |
Methods of detoxification and their role in treating patients with opioid dependence.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Failure | 2005 |
Histological changes over time around the site of sustained release naltrexone-poly(DL-lactide) implants in humans.
Topics: Biocompatible Materials; Drug Implants; Female; Fibrosis; Foreign-Body Reaction; Heroin Dependence; Humans; Male; Microspheres; Naltrexone; Narcotic Antagonists; Necrosis; Polyesters; Skin; Subcutaneous Fat; Time Factors | 2005 |
Naltrexone implants as treatment for heroin dependence: part I.
Topics: Drug Administration Routes; Drug Implants; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists | 2005 |
Naltrexone implants as treatment for heroin dependence: part II.
Topics: Drug Implants; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Randomized Controlled Trials as Topic | 2005 |
Severe uncontrolled pain in buttock in a patient on naltrexone: a diagnostic challenge.
Topics: Adult; Analgesics, Opioid; Buttocks; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Pain Measurement; Pain, Intractable; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Naltrexone and buprenorphine combination in the treatment of opioid dependence.
Topics: Adult; Affect; Buprenorphine; Cocaine; Cocaine-Related Disorders; Female; Heroin Dependence; Humans; Liver; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Psychiatric Status Rating Scales; Substance Abuse Detection; Survival Analysis | 2006 |
Heroin detoxification.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Drug Therapy, Combination; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2006 |
Heroin detoxification.
Topics: Anesthesia, General; Buprenorphine; Clonidine; Drug Therapy, Combination; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2006 |
Heroin dependence and HIV infection in Malaysia.
Topics: Adult; Buprenorphine; Demography; Female; Heroin Dependence; HIV Infections; Humans; Malaysia; Male; Naltrexone; Narcotic Antagonists; Prevalence; Risk-Taking | 2006 |
Naltrexone for probationers and parolees.
Topics: Commitment of Mentally Ill; Counseling; Crime; Forensic Psychiatry; Heroin Dependence; Humans; Illicit Drugs; Naltrexone; Narcotic Antagonists; Patient Compliance; Prisoners; Recurrence; United States | 2006 |
Judicially mandated naltrexone use by criminal offenders: a legal analysis.
Topics: Crime; Forensic Medicine; Heroin Dependence; Humans; Mental Health Services; Naltrexone; Narcotic Antagonists; Patient Compliance; United States | 2006 |
Naltrexone as a "mandate" or as a choice comments on "Judicially mandated naltrexone use by criminal offenders: a legal analysis".
Topics: Crime; Forensic Medicine; Heroin Dependence; Humans; Mandatory Programs; Mental Health Services; Naltrexone; Narcotic Antagonists; Patient Compliance; Philadelphia | 2006 |
Depot naltrexone in lieu of incarceration: a behavioral analysis of coerced treatment for addicted offenders.
Topics: Behavior Therapy; Behavior, Addictive; Coercion; Delayed-Action Preparations; Heroin Dependence; Humans; Mental Health Services; Naltrexone; Narcotic Antagonists; Prisons; Punishment; Reinforcement, Psychology | 2006 |
Naltrexone-assisted rapid methadone discontinuation: a pilot study.
Topics: Adult; Drug Evaluation, Preclinical; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pilot Projects; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Regarding naltrexone for probationers and parolees.
Topics: Buprenorphine; Heroin Dependence; Humans; Injections; Long-Term Care; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pain; Prisoners; Treatment Outcome | 2007 |
Overcoming opioid blockade from depot naltrexone (Prodetoxon).
Topics: Adult; Drug Implants; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Naltrexone; Narcotic Antagonists; Secondary Prevention; Substance Withdrawal Syndrome | 2007 |
Does naltrexone affect craving in abstinent opioid-dependent patients?
Topics: Adult; Female; Heroin; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Middle Aged; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Secondary Prevention; Substance Abuse Detection; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2007 |
Lack of information in naltrexone study.
Topics: Decision Trees; Delayed-Action Preparations; Heroin Dependence; Humans; Injections; Naltrexone; Narcotic Antagonists; Patient Dropouts; Patient Selection; Randomized Controlled Trials as Topic; Research Design | 2007 |
Management of relapse in naltrexone maintenance for heroin dependence.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Heroin Dependence; Humans; Inpatients; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Outpatients; Recurrence; Time Factors | 2007 |
Pharmacotherapeutic environments for substance use disorders.
Topics: Ambulatory Care; Buprenorphine; Cognitive Behavioral Therapy; Delayed-Action Preparations; Family Practice; Heroin Dependence; Hospitalization; Humans; Methadone; Naltrexone; Office Visits; Opioid-Related Disorders; Secondary Prevention; Substance-Related Disorders | 2007 |
A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
Topics: Administration, Oral; Adult; Cohort Studies; Female; Heroin Dependence; Hospitalization; Humans; Incidence; Male; Medical Record Linkage; Mental Disorders; Naltrexone; Narcotic Antagonists; Risk Factors; Treatment Outcome; Western Australia | 2007 |
Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
Topics: Adult; Cohort Studies; Databases, Factual; Drug Implants; Drug Overdose; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Suicide; Time Factors; Western Australia | 2008 |
Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program.
Topics: Administration, Oral; Adult; Clinical Protocols; Delayed-Action Preparations; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; New South Wales; Rehabilitation, Vocational; Retrospective Studies; Social Support; Socioeconomic Factors; Substance Abuse Detection; Treatment Outcome | 2007 |
Toward a rational selection of treatment for addiction.
Topics: Alleles; Buprenorphine; Genetic Variation; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Substance-Related Disorders | 2007 |
Prooxidative/antioxidative homeostasis in heroin addiction and detoxification.
Topics: Adult; Antioxidants; Female; Heroin Dependence; Homeostasis; Humans; Lipid Peroxidation; Male; Naltrexone; Narcotic Antagonists; Oxidative Stress; Reactive Oxygen Species | 2007 |
Acute and chronic heroin dependence in mice: contribution of opioid and excitatory amino acid receptors.
Topics: Acute Disease; Animals; Behavior, Animal; Benzylidene Compounds; Chronic Disease; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Heroin Dependence; Male; Mice; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Time Factors | 2008 |
Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
Topics: Adult; Diagnostic and Statistical Manual of Mental Disorders; Drug Implants; Female; Follow-Up Studies; Heroin Dependence; Hospitalization; Humans; Male; Methadone; Morbidity; Naltrexone; Narcotics; Prevalence; Prospective Studies; Retrospective Studies | 2008 |
Unplanned admissions to two Sydney public hospitals after naltrexone implants.
Topics: Adult; Drug Implants; Female; Heroin Dependence; Hospitals, Public; Humans; Incidence; Male; Naltrexone; Narcotic Antagonists; New South Wales; Patient Admission; Retrospective Studies; Substance Withdrawal Syndrome; Time Factors | 2008 |
Use of naltrexone to extinguish opioid-conditioned responses.
Topics: Adult; Combined Modality Therapy; Conditioning, Classical; Extinction, Psychological; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Recurrence; Relaxation Therapy | 1984 |
Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Follow-Up Studies; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Recurrence | 1984 |
Naltrexone: a clinical perspective.
Topics: Adult; Alcohol Drinking; Ambulatory Care; Follow-Up Studies; Heroin Dependence; Hospitalization; Humans; Middle Aged; Naloxone; Naltrexone; Opioid-Related Disorders; Patient Dropouts; Social Support; Substance Withdrawal Syndrome | 1984 |
Clinical experience with naltrexone in suburban opioid addicts.
Topics: Adult; Ambulatory Care; Combined Modality Therapy; Female; Guanabenz; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Opioid-Related Disorders; Patient Dropouts; Psychotherapy; Suburban Population; Time Factors | 1984 |
Naltrexone treatment of heroin addiction: one-year follow-up.
Topics: Adult; Age Factors; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadyl Acetate; Motivation; Naloxone; Naltrexone | 1984 |
Methadone and naltrexone in the treatment of heroin dependence.
Topics: Heroin Dependence; Humans; Methadone; Naloxone; Naltrexone; Psychotherapy; Substance Withdrawal Syndrome; Time Factors | 1984 |
Opiate use and sexual function.
Topics: Erectile Dysfunction; Follicle Stimulating Hormone; Heroin Dependence; Humans; Luteinizing Hormone; Male; Naltrexone; Testosterone | 1980 |
Treatment of heroin-dependent persons with antagonists: current status.
Topics: Heroin Dependence; History, 20th Century; Humans; Naltrexone; Narcotic Antagonists | 1981 |
Historical perspective on the chemistry and development of naltrexone.
Topics: Animals; Benzomorphans; Heroin Dependence; History, 20th Century; Humans; Morphine; Naloxone; Naltrexone; Narcotic Antagonists | 1981 |
Naltrexone and psychotherapy.
Topics: Heroin Dependence; Humans; Naloxone; Naltrexone; Psychotherapy | 1982 |
Outpatient opiate detoxification with clonidine.
Topics: Ambulatory Care; Clonidine; Double-Blind Method; Drug Therapy, Combination; Heroin Dependence; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1982 |
The clinical use of clonidine in outpatient detoxification from opiates.
Topics: Clonidine; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Self Administration; Substance Withdrawal Syndrome | 1981 |
Effects of heroin and naltrexone on plasma prolactin levels in man.
Topics: Adult; Heroin; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Prolactin | 1980 |
Heroin and naltrexone effects on pituitary-gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity.
Topics: Adult; Drug Tolerance; Feedback; Heroin Dependence; Humans; Luteinizing Hormone; Male; Naloxone; Naltrexone; Testosterone; Time Factors | 1980 |
The treatment of heroin addiction: naltrexone alone and with behavior therapy.
Topics: Adult; Behavior Therapy; Extinction, Psychological; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Outcome and Process Assessment, Health Care; Patient Dropouts | 1980 |
[Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
Topics: Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Narcotics; Patient Compliance; Portugal; Substance-Related Disorders; Time Factors | 1994 |
A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR.
Topics: Adult; Clonidine; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Neurologic Examination; Opioid-Related Disorders; Patient Dropouts; Recurrence; Treatment Outcome; USSR | 1994 |
A 24-h inpatient detoxification treatment for heroin addicts: a preliminary investigation.
Topics: Administration, Oral; Adult; Conscious Sedation; Drug Administration Schedule; Follow-Up Studies; Guanfacine; Heroin Dependence; Humans; Intensive Care Units; Length of Stay; Male; Midazolam; Naltrexone; Neurologic Examination; Patient Admission; Premedication; Substance Abuse Detection; Substance Withdrawal Syndrome | 1994 |
Effects of opiates on blood rheology.
Topics: Adult; Cell Aggregation; Female; Fibrinogen; Hemorheology; Heroin; Heroin Dependence; Humans; Leukocytes; Male; Naltrexone; Prothrombin Time | 1994 |
Role of increase of opioid receptors in granulocyte CD11b/CD18 dysfunction.
Topics: Adult; Antigens, CD; CD18 Antigens; Female; Granulocytes; Heroin Dependence; Humans; Macrophage-1 Antigen; Male; Methadone; Naltrexone; Phagocytosis; Receptors, Opioid | 1993 |
Heroin withdrawal precipitated by nonmedical use of naltrexone.
Topics: Adult; Heroin; Heroin Dependence; Humans; Male; Naltrexone; Self Medication; Substance Withdrawal Syndrome | 1993 |
Ultrashort noninvasive opiate detoxification.
Topics: Adult; Heroin Dependence; Humans; Male; Midazolam; Naloxone; Naltrexone; Ondansetron; Substance Withdrawal Syndrome; Time Factors | 1993 |
Biocompatibility and in vivo morphine diffusion into a placebo morphine-triggered naltrexone delivery device in rabbits.
Topics: Animals; Biocompatible Materials; Biotransformation; Female; Heroin Dependence; Infusion Pumps, Implantable; Injections, Intravenous; Materials Testing; Morphine; Naltrexone; Rabbits | 1995 |
Within-session determination of dose-response curves for heroin self-administration in rats: Comparison with between-session determination and effects of naltrexone.
Topics: Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Heroin; Heroin Dependence; Male; Motivation; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred F344; Reinforcement Schedule; Self Administration | 1996 |
Rapid opiate detoxification.
Topics: Adult; Anesthetics, Intravenous; Critical Care; Female; Heroin Dependence; Humans; Hypnotics and Sedatives; Length of Stay; Male; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Neuromuscular Nondepolarizing Agents; Propofol; Respiration, Artificial; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Vecuronium Bromide | 1996 |
Managing pain in addicted patients.
Topics: Alcoholism; Analgesics; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Pain; Recurrence; Substance-Related Disorders | 1997 |
What you need to know: addiction--prescribing naltrexone.
Topics: Alcoholism; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 1997 |
Ultrarapid opiate detoxification. What's all the fuss about?
Topics: Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Naltrexone; Narcotic Antagonists | 1997 |
Ultrarapid opiate detoxification.
Topics: Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Naltrexone; Narcotic Antagonists | 1997 |
Addict died after rapid opiate detoxification.
Topics: Anesthesia; Death, Sudden; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Malpractice; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 1998 |
Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: comparison with alteration of [3H]DAMGO binding to rat brain sections.
Topics: Analgesics, Opioid; Animals; Brain; Caudate Nucleus; Cocaine; Culture Techniques; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Heroin; Heroin Dependence; Motivation; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Radioligand Assay; Rats; Receptors, Opioid, mu; Self Administration | 1998 |
Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.
Topics: Adult; Dose-Response Relationship, Drug; Female; Heroin Dependence; Humans; Italy; Male; Methadone; Naltrexone; Patient Dropouts | 1998 |
Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts.
Topics: Administration, Oral; Adult; Biological Availability; Female; Heroin Dependence; Humans; Long-Term Care; Male; Metabolic Clearance Rate; Naltrexone; Narcotic Antagonists | 1998 |
Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.
Topics: Administration, Oral; Adolescent; Adult; Anesthesia, General; Clonidine; Drug Therapy, Combination; Feasibility Studies; Female; Follow-Up Studies; Heroin Dependence; Humans; Hypnotics and Sedatives; Length of Stay; Male; Methadone; Midazolam; Naltrexone; Narcotic Antagonists; Neurologic Examination; Ondansetron; Substance Withdrawal Syndrome; Treatment Outcome | 1998 |
A morphine-triggered delivery system useful in the treatment of heroin addiction.
Topics: Biodegradation, Environmental; Drug Delivery Systems; Heroin Dependence; Humans; Lipase; Materials Testing; Membranes, Artificial; Microspheres; Molecular Structure; Morphine; Naltrexone; Polymers; Porosity | 1993 |
Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Calcium; Female; Heroin Dependence; Humans; Hydrocortisone; Leukocytes; Male; Naltrexone; Narcotic Antagonists; Neutrophils; Receptors, Opioid | 1999 |
Is naltrexone a cure for heroin dependence?
Topics: Australia; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Pilot Projects; Substance Withdrawal Syndrome | 1999 |
Serendipitous rapid detoxification from opiates: the importance of time-dependent processes.
Topics: Adult; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome; Time Factors | 1999 |
Active surveillance of adverse events associated with naltrexone in New South Wales.
Topics: Adult; Data Collection; Female; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; New South Wales; Opioid-Related Disorders | 1999 |
Is there a pharmacological basis for therapy with rapid opioid detoxification?
Topics: Anesthesia, General; Animals; Conscious Sedation; Cyclic AMP Response Element-Binding Protein; Heroin Dependence; Humans; Mice; Mice, Knockout; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Signal Transduction; Substance Withdrawal Syndrome; Treatment Outcome | 1999 |
Rapid heroin detoxification under general anesthesia.
Topics: Anesthesia, General; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists | 2000 |
Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
Topics: Adult; Anesthesia, General; Codeine; Female; Heroin Dependence; Humans; Male; Methadone; Morphine Dependence; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Prospective Studies; Substance Withdrawal Syndrome | 2000 |
Gypsies and drug addictions. Study of the adherence to treatment.
Topics: Adult; Cohort Studies; Cross-Cultural Comparison; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Compliance; Retrospective Studies; Roma; Spain | 2000 |
Development of rhabdomyolysis after rapid opioid detoxification with subcutaneous naltrexone maintenance therapy.
Topics: Adolescent; Gastrointestinal Hemorrhage; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Mallory-Weiss Syndrome; Naltrexone; Narcotic Antagonists; Rhabdomyolysis; Shock; Time Factors; Vomiting | 2000 |
Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Carbon Dioxide; Dose-Response Relationship, Drug; Drug Tolerance; Heroin; Heroin Dependence; Macaca mulatta; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Respiration; Time Factors | 2000 |
Morphine stimulates mesangial cell TNF-alpha and nitrite production.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Transformed; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Heroin Dependence; HIV Envelope Protein gp120; HIV Infections; Lipopolysaccharides; Macrophages; Mice; Morphine; Muscle, Smooth, Vascular; Naloxone; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitrites; Tumor Necrosis Factor-alpha | 2000 |
Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program--a retrospective follow-up study.
Topics: Adult; Female; Follow-Up Studies; Heroin Dependence; Humans; Israel; Length of Stay; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Outcome and Process Assessment, Health Care; Patient Admission; Pilot Projects; Recurrence | 2000 |
Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
Topics: Adult; Aged; Brain; Female; Fluorine Radioisotopes; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Naltrexone; Receptors, Opioid, kappa; Receptors, Opioid, mu; Tomography, Emission-Computed | 2000 |
Thyroid function of former opioid addicts on naltrexone treatment.
Topics: Adult; Female; Heroin Dependence; Humans; Interleukin-6; Male; Naltrexone; Narcotic Antagonists; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2001 |
Prevention of suicide by naltrexone in a recently detoxified heroin addict.
Topics: Adult; Drug Overdose; Heroin Dependence; Humans; Male; Naltrexone; Suicide Prevention; Time Factors | 2001 |
Acute opioid withdrawal in the emergency department: inadvertent naltrexone abuse?
Topics: Acute Disease; Adult; Colic; Emergency Medical Services; Female; Heroin; Heroin Dependence; Humans; Injections, Intravenous; Naltrexone; Narcotics; Substance Withdrawal Syndrome; Vomiting | 2001 |
Unintentional rapid opioid detoxification.
Topics: Adult; Female; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome | 2001 |
[The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Narcotic Antagonists; Scopolamine | 1999 |
Conflict for the court.
Topics: Drug Implants; Female; Heroin Dependence; Humans; Informed Consent; Malpractice; Naltrexone; Narcotic Antagonists; New Jersey | 2001 |
Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Topics: Buprenorphine; Electrocardiography; Heroin Dependence; Humans; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Time Factors | 2001 |
Obstetric and neonatal outcomes associated with maternal naltrexone exposure.
Topics: Adult; Australia; Female; Heroin Dependence; Humans; Infant, Newborn; Naltrexone; Narcotic Antagonists; Portugal; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; United Kingdom | 2001 |
[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].
Topics: Controlled Clinical Trials as Topic; Evidence-Based Medicine; Heroin Dependence; Humans; Meta-Analysis as Topic; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Naltrexone for opioid dependence. An additional tool for general practitioners.
Topics: Disease Management; Family Practice; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists | 2002 |
[Documented effect of methadone, but not naltrexone].
Topics: Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2002 |
[Methadone and naltrexone in heroin addiction--an explanation from the SBU].
Topics: Evidence-Based Medicine; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Social Support; Sweden | 2002 |
A possible role for implantable naltrexone in the management of the high-risk pregnant heroin user.
Topics: Adult; Dose-Response Relationship, Drug; Drug Implants; Female; Follow-Up Studies; Gestational Age; Heroin Dependence; Humans; Maternal-Fetal Exchange; Naltrexone; Narcotic Antagonists; Patient Compliance; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Substance Withdrawal Syndrome; Treatment Outcome | 2002 |
Unreinforced self-injections: effects on rituals and outcome in heroin addicts.
Topics: Extinction, Psychological; Follow-Up Studies; Heroin Dependence; Humans; Hydromorphone; Male; Naloxone; Naltrexone; Reinforcement, Psychology; Research Design; Self Administration | 1979 |
Aversiveness of oral methadone in rats.
Topics: Animals; Choice Behavior; Decision Making; Heroin Dependence; Humans; Male; Methadone; Models, Psychological; Naltrexone; Quinine; Rats; Self Administration; Taste; Time Factors | 1978 |
Heroin self-administration: an operant analysis.
Topics: Conditioning, Operant; Disease Models, Animal; Heroin Dependence; Humans; Male; Naltrexone; Placebos; Reinforcement Schedule; Self Administration | 1978 |
Historical trends in naltrexone research.
Topics: Heroin Dependence; History, 20th Century; Humans; Naloxone; Naltrexone; Research; United States | 1978 |
Naltrexone: the clinical investigator's dilemma.
Topics: Adolescent; Adult; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Patient Dropouts; Research Design; Social Adjustment; United States | 1978 |
The future of naltrexone.
Topics: Adolescent; Adult; Endorphins; Female; Forecasting; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Patient Compliance; United States | 1978 |
Naltrexone and behavior therapy for heroin addiction.
Topics: Adult; Behavior Therapy; California; Dose-Response Relationship, Drug; Ethnicity; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Naloxone; Naltrexone | 1979 |
Heroin and naltrexone effects on pituitary-gonadal hormones in man: tolerance and supersensitivity.
Topics: Adult; Heroin; Heroin Dependence; Humans; Luteinizing Hormone; Male; Naloxone; Naltrexone; Prolactin; Testosterone | 1979 |
Modification of treatment compliance as a function of contingent payment manipulations.
Topics: Adult; Heroin Dependence; Humans; Naloxone; Naltrexone; Patient Compliance; Reinforcement, Psychology | 1979 |
The clinical usefulness of narcotic antagonists: implications of behavioral research.
Topics: Aftercare; Behavior Therapy; Conditioning, Operant; Cyclazocine; Extinction, Psychological; Heroin; Heroin Dependence; Hospitalization; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Patient Dropouts; Reinforcement, Psychology; Research Design; Self-Assessment | 1975 |
Analysis and modification of opiate reinforcement.
Topics: Adult; Aftercare; Behavior Therapy; Boston; Cyclazocine; Follow-Up Studies; Heroin Dependence; Humans; Male; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Patient Dropouts; Reinforcement, Psychology; Token Economy | 1976 |
Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study.
Topics: Adult; Aftercare; Behavior Therapy; Boston; Conditioning, Operant; Evaluation Studies as Topic; Heroin Dependence; Humans; Male; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Research Design; Satiation; Token Economy | 1976 |
Aftercare on narcotic antagonists: prospects and problems.
Topics: Adult; Aftercare; Attitude; Boston; Employment; Evaluation Studies as Topic; Follow-Up Studies; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Dropouts; Psychological Tests; Social Control, Formal; Time Factors | 1976 |
Naltrexone in the management of heroin addiction: critique of the rationale.
Topics: Conditioning, Psychological; Heroin Dependence; Humans; Impulsive Behavior; Motivation; Naloxone; Naltrexone; Peptides; Receptors, Opioid | 1976 |
Methadone maintenance and narcotic blocking drugs.
Topics: Aftercare; Cyclazocine; Extinction, Psychological; Heroin Dependence; Hospitalization; Humans; Levallorphan; Methadone; Nalorphine; Naloxone; Naltrexone; Narcotic Antagonists; Psychotherapy; Receptors, Opioid | 1977 |
Naltrexone in the treatment of opiate dependence.
Topics: Adolescent; Adult; Follow-Up Studies; Forecasting; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Narcotics; New York City; Psychotherapy; Receptors, Opioid; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders | 1978 |
Research and development of naltrexone: a new narcotic antagonist.
Topics: Financing, Government; Heroin Dependence; Humans; Legislation, Drug; Naloxone; Naltrexone; Receptors, Opioid; Research; United States | 1979 |
Effects of contingent payment on compliance with a naltrexone regimen.
Topics: Adult; Behavior Therapy; Consumer Behavior; Heroin Dependence; Humans; Length of Stay; Male; Naloxone; Naltrexone; Patient Compliance; Reinforcement Schedule | 1979 |
Narcotic antagonist treatment: clinical experience with naltrexone.
Topics: Adolescent; Adult; Attitude; Drug Evaluation; Emotions; Employment; Follow-Up Studies; Heroin Dependence; Humans; Male; Middle Aged; Naloxone; Naltrexone; Patient Compliance; Psychiatric Status Rating Scales; Time Factors | 1978 |
Naltrexone and conventionality.
Topics: Adolescent; Adult; Crime; Drug Evaluation; Economics; Employment; Heroin Dependence; Humans; Life Style; Male; Marriage; Middle Aged; Naloxone; Naltrexone; Patient Compliance; Residence Characteristics; Social Conformity | 1978 |
Craving in heroin addicts maintained on the opiate antagonist naltrexone.
Topics: Heroin Dependence; Humans; Naloxone; Naltrexone; Patient Dropouts | 1978 |
Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Heroin Dependence; Humans; Male; Methadone; Methods; Naloxone; Naltrexone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1977 |
Pharmacotherapy of opiate addiction.
Topics: Adolescent; Adult; Cyclazocine; Female; Heroin Dependence; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Opium; Substance-Related Disorders; United States | 1976 |
A behavioral paradigm for the evaluation of narcotic antagonists.
Topics: Adult; Cyclazocine; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; Narcotic Antagonists; Research Design | 1976 |
Psychopathology and mood during heroin use: acute vs chronic effects.
Topics: Acute Disease; Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Emotions; Euphoria; Heroin; Heroin Dependence; Humans; Male; Methadone; Morphine; Motor Activity; Naloxone; Naltrexone; Psychopathology | 1976 |
Short-term effects of naltrexone in 155 heroin ex-addicts.
Topics: Abdomen; Administration, Oral; Blood Pressure; Brain; Dose-Response Relationship, Drug; Drug Evaluation; Heart; Heroin Dependence; Humans; Naloxone; Naltrexone; Pain; Respiration; Substance-Related Disorders; Time Factors | 1976 |
Narcotic antagonists: naltrexone progress report: foreword.
Topics: Cyclazocine; Government Agencies; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; United States | 1976 |
Clinical efficacy of naltrexone: a one year follow up.
Topics: Adult; Follow-Up Studies; Heroin Dependence; Humans; Naloxone; Naltrexone; Time Factors | 1976 |
Treatment of heroin dependence with naltrexone.
Topics: Heroin Dependence; Humans; Naloxone; Naltrexone | 1975 |
A unit for delivering multiple drug treatment and prevention services.
Topics: Adolescent; Adult; Community Mental Health Services; Connecticut; Cyclazocine; Heroin Dependence; Humans; Methadone; Naltrexone; Psychotherapy, Group; Substance-Related Disorders; Vocational Education | 1975 |
On the role of chemotherapy in the treatment of heroin addiction.
Topics: Heroin Dependence; Humans; Methadone; Methadyl Acetate; Motivation; Naloxone; Naltrexone; Substance-Related Disorders | 1975 |
Naltrexone pharmacology, pharmacokinetics, and metabolism: current status.
Topics: Administration, Oral; Animals; Biological Availability; Biotransformation; Chickens; Delayed-Action Preparations; Dogs; Drug Evaluation, Preclinical; Guinea Pigs; Half-Life; Heroin Dependence; Humans; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Mice; Naloxone; Naltrexone; Rats; Species Specificity; Time Factors | 1975 |
Clinical experience with naltrexone.
Topics: Administration, Oral; Adult; Female; Heroin Dependence; Hospitalization; Humans; Male; Methadone; Middle Aged; Morphine; Naloxone; Naltrexone; Outpatient Clinics, Hospital; Patient Dropouts; Placebos; Time Factors | 1975 |
The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone.
Topics: Adult; Alcoholism; Boston; Cannabis; Depression; Emotions; Follow-Up Studies; Heroin Dependence; Humans; Internal-External Control; Male; Naloxone; Naltrexone; Patient Acceptance of Health Care; Patient Dropouts; Psychotherapy; Self Concept; Sleep | 1975 |
Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic.
Topics: Administration, Oral; Ambulatory Care; Educational Status; Employment; Ethnicity; Female; Heroin Dependence; Humans; Male; Naloxone; Naltrexone; New York City; Patient Dropouts | 1975 |
Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
Topics: Adult; Heroin Dependence; Homicide; Humans; Male; Methadone; Methadyl Acetate; Naloxone; Naltrexone; Psychotropic Drugs; Substance-Related Disorders; Suicide | 1975 |
Naltrexone study guidelines: good vehicle--wrong destination.
Topics: Drug Evaluation; Heroin Dependence; Humans; Motivation; Naloxone; Naltrexone; Research Design | 1975 |
Heroin addiction. Sequential treatment employing pharmacologic supports.
Topics: Heroin Dependence; Humans; Methadone; Morphine; Naltrexone; Prognosis; Recurrence | 1976 |
Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction.
Topics: Animals; Conditioning, Operant; Extinction, Psychological; Heroin Dependence; Injections, Intravenous; Morphine; Nalorphine; Naltrexone; Rats; Rats, Sprague-Dawley; Self Administration | 1992 |
Clinical parallels of chronic drug self-administration models for treatment evaluation.
Topics: Adult; Buprenorphine; Conditioning, Operant; Heroin Dependence; Humans; Male; Models, Biological; Naltrexone; Self Administration | 1992 |
Experience with clonidine-naltrexone for rapid opiate detoxification.
Topics: Adult; Clonidine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Middle Aged; Naltrexone; Neurologic Examination; Substance Withdrawal Syndrome | 1991 |
Naltrexone for heroin addiction: encouraging results from Italy.
Topics: Adult; Female; Heroin Dependence; Humans; Italy; Male; Naltrexone; Narcotics; Patient Compliance | 1990 |
NIDA's Medication Development Program--1989.
Topics: Acquired Immunodeficiency Syndrome; Brain; Cocaine; Drug and Narcotic Control; Female; Heroin Dependence; Humans; Infant, Newborn; Methadone; Methadyl Acetate; Naltrexone; Pregnancy; Psychotropic Drugs; Research Support as Topic; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders | 1989 |
False positive urine drug screens from quinine in tonic water.
Topics: Adult; Alcoholism; Heroin; Heroin Dependence; Humans; Male; Middle Aged; Mineral Waters; Naltrexone; Patient Compliance; Quinine | 1989 |
Endogenous opioids in cerebrospinal fluid of opioid-dependent humans.
Topics: Adult; beta-Endorphin; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Radioimmunoassay; Radioligand Assay; Receptors, Opioid; Substance Withdrawal Syndrome | 1988 |
Role of pituitary and related neuropeptides in alcoholism and pharmacodependence.
Topics: Adrenocorticotropic Hormone; Alcoholism; Animals; Arginine Vasopressin; beta-Endorphin; Brain; Endorphins; Haplorhini; Heroin Dependence; Humans; Melanocyte-Stimulating Hormones; Naltrexone; Neurotransmitter Agents; Peptides; Pituitary Gland; Rats; Reinforcement, Psychology; Reward; Substance-Related Disorders | 1986 |
A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts.
Topics: Adolescent; Adult; beta-Endorphin; Circadian Rhythm; Endorphins; Heroin Dependence; Humans; Hydrocortisone; Naltrexone; Substance Withdrawal Syndrome | 1986 |
Chronic naltrexone suppresses platelet aggregation induced by adrenaline and 5-hydroxytryptamine in former heroin addicts.
Topics: Adult; Epinephrine; Female; Heroin Dependence; Humans; Male; Naltrexone; Platelet Aggregation; Reference Values; Serotonin | 1988 |
Naltrexone: lack of effect on hepatic enzymes.
Topics: Adult; Aspartate Aminotransferases; Heroin Dependence; Humans; L-Lactate Dehydrogenase; Liver; Liver Function Tests; Male; Methadone; Naltrexone; Substance-Related Disorders; Time Factors | 1988 |
Primary care of parenteral substance abusers.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Antibodies, Viral; Body Weight; Cocaine; Female; Heart Diseases; Hepatitis; Heroin Dependence; HIV Antibodies; Humans; Injections, Intradermal; Injections, Intravenous; Kidney Diseases; Male; Menstruation Disturbances; Methadone; Naltrexone; Nervous System Diseases; Primary Health Care; Respiratory Tract Diseases; Substance-Related Disorders | 1986 |
[New supportive therapy with naltrexone. Care of heroin addiction in the United States].
Topics: Administration, Oral; Drug Administration Schedule; Heroin Dependence; Humans; Naltrexone; United States | 1987 |
Naltrexone: helping the heroin user to get clean and stay clean.
Topics: Heroin Dependence; Humans; Naltrexone | 1986 |
Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts.
Topics: Adult; Circadian Rhythm; Female; Heroin Dependence; Humans; Hydrocortisone; Male; Naltrexone | 1986 |
Clinical use of naltrexone (EN-1639A): Part I: Safety and efficacy in pilot studies.
Topics: Adult; Ambulatory Care; Drug Evaluation; Female; Heroin Dependence; Humans; Legislation, Drug; Male; Middle Aged; Naloxone; Naltrexone; Nausea; New York City; Pilot Projects; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; United States | 1974 |